SCHEMBL6668752

SCHEMBL6668752

O=C(NCCc1ccc(Cl)cc1)c1n[nH]c2c(C#Cc3ccccc3)cc(CC3CCOCC3)cc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 3/20 0.40
NPC1 O15118 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
ABCB1 P08183 1/20 0.36
TP53 P04637 1/20 0.36
GALR3 O60755 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
LMNA P02545 2/20 0.35
PLK4 O00444 1/20 0.34
AURKA O14965 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6666113 0.86 RAB9A (0.47) RAB9AKMT2AMEN1GAAMAPT
SCHEMBL6668749 0.84 NR1H4 (0.36) GAAMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL6694399 0.78 MAPT (0.41) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL7477339 0.74 NR1H4 (0.35) GAANPC1ALDH1A1TP53KDM4E
SCHEMBL6669484 0.74 MAPK1 (0.36) KMT2AMEN1GAAABCB1TP53
SCHEMBL6672672 0.74 NR1H4 (0.34) NPC1SMN1; SMN2
SCHEMBL6672237 0.72 NR1H4 (0.33) KMT2AMEN1
SCHEMBL6667472 0.72 MEN1 (0.41) RAB9AKMT2AMEN1GAAMAPT
SCHEMBL6666111 0.72 NR1H4 (0.37) GAANPC1SMN1; SMN2ALDH1A1HTT
SCHEMBL6668160 0.69 KMT2A (0.49) KMT2AMEN1GAAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed